4ys7
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Co-crystal structure of 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imidazo[4,5-f]quinoline (compound 39) with PDE10A== | ==Co-crystal structure of 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imidazo[4,5-f]quinoline (compound 39) with PDE10A== | ||
<StructureSection load='4ys7' size='340' side='right' caption='[[4ys7]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='4ys7' size='340' side='right' caption='[[4ys7]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4GK:2-[2-(5,8-DIMETHYL[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-2-YL)ETHYL]-3-METHYL-3H-IMIDAZO[4,5-F]QUINOLINE'>4GK</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4GK:2-[2-(5,8-DIMETHYL[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-2-YL)ETHYL]-3-METHYL-3H-IMIDAZO[4,5-F]QUINOLINE'>4GK</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4yqh|4yqh]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4yqh|4yqh]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ys7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ys7 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ys7 RCSB], [http://www.ebi.ac.uk/pdbsum/4ys7 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ys7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ys7 OCA], [http://pdbe.org/4ys7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4ys7 RCSB], [http://www.ebi.ac.uk/pdbsum/4ys7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4ys7 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 17: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4ys7" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Phosphodiesterase|Phosphodiesterase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 09:52, 10 March 2017
Co-crystal structure of 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imidazo[4,5-f]quinoline (compound 39) with PDE10A
| |||||||||||
